GM
$33.60
-0.81
(-2.35%)
As of Sep 5, 2026, 4:38 PM EDT
Price history
Genmab A/s (GMAB) is trading down at $33.60 (-2.35%), as of the latest quote. It operates in the sector.
IPO: July 18, 2019 · $17.75 offering · NASDAQ · View IPO details →
Recent News (4)
-
Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle?
Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle?
-
Genmab to Participate in Upcoming Investor Conferences Media Release COPENHAGEN, Denmark; August 25, 2026 Genmab A/S (Nasdaq: GMAB) announced today that members of its Executive Committee will participate in fireside chats at the following investor confer…
-
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
-
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab? Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab? Yahoo Finance